Acne
Vulgaris
by Julie C
Harper, American
Academy Of Dermatology
|
Background:
Acne
vulgaris is a common skin disease that affects
85-100% of people at some time during their lives.
It is characterized by noninflammatory follicular
papules or comedones and by inflammatory papules,
pustules, and nodules in its more severe forms. Acne
vulgaris affects the areas of skin with the densest
population of sebaceous follicles; these areas
include the face, the upper part of the chest, and
the back.
Pathophysiology:
The pathogenesis of acne vulgaris is
multifactorial. Four key factors are responsible for
the development of an acne lesion. These factors are
follicular epidermal hyperproliferation with
subsequent plugging of the follicle, excess sebum,
the presence and activity of Propionibacterium
acnes, and inflammation.
Follicular
epidermal hyperproliferation is the first recognized
event in the development of acne. The exact
underlying cause of this hyperproliferation is not
known. Currently, the 3 leading hypotheses have been
proposed to explain why the follicular epithelium is
hyperproliferative in individuals with acne.
First,
androgen hormones have been implicated as the
initial trigger. Comedones, the clinical lesion that
results from follicular plugging, begin to appear
around adrenarche in persons with acne. Furthermore,
the degree of comedonal acne in prepubertal girls
correlates with circulating levels of the adrenal
androgen dehydroepiandrosterone sulfate (DHEA-S).
Additionally, androgen hormone receptors are present
in the portion of the follicle where the comedone
forms; individuals with malfunctioning androgen
receptors do not develop acne.
Continued
Below... |
|
 |
|
|
|
Continued...
Second,
changes in lipid composition have been implicated in
the development of acne vulgaris. Persons with acne
frequently have excess sebum production and oily
skin. This excess sebum may dilute the normal
epidermal lipids and result in a change in the
relative concentrations of the various lipids.
Diminished concentrations of linoleic acid have been
demonstrated in individuals with acne and,
interestingly, these levels normalize after
successful treatment with isotretinoin. This
relative decrease in linoleic acid may be what
initiates comedone formation.
Inflammation
is the third hypothesized factor incriminated in
comedone formation. Interleukin (IL)–1–alpha is
a proinflammatory cytokine. It has been used in a
tissue model to induce follicular epidermal
hyperproliferation and comedone formation. Although
inflammation is not apparent microscopically or
clinically in early lesions of acne, it may still
play a pivotal role in the development of acne
vulgaris and the comedones.
Excess
sebum is another key factor in the development of
acne vulgaris. Sebum production and excretion are
regulated by a number of different hormones and
mediators. Androgen hormones, in particular, promote
sebum production and release. Still, most men and
women with acne have normal circulating levels of
androgen hormones. An end-organ hyperresponsiveness
to androgen hormones has been hypothesized. Androgen
hormones are not the only regulators of the human
sebaceous gland. Numerous other agents, including
growth hormone and insulinlike growth factor, also
regulate the sebaceous gland and may contribute to
the development of acne.
P
acnes is a microaerophilic organism present in
many acne lesions. Although, it has not been shown
to be present in the earliest lesions of acne, the
microcomedo, its presence in later lesions is almost
certain. The presence of P acnes promotes
inflammation through a variety of mechanisms. P
acnes stimulates inflammation by producing
proinflammatory mediators that diffuse through the
follicle wall. Recent studies have shown that P
acnes binds to the toll-like receptor 2 on
monocytes and neutrophils. Binding of the toll-like
receptor 2 then leads to the production of multiple
proinflammatory cytokines, including IL-12, IL-8,
and tumor necrosis factor. Hypersensitivity to P
acnes may also explain why some individuals
develop inflammatory acne vulgaris while others do
not.
Inflammation
may be a primary phenomenon or a secondary
phenomenon. Most of the evidence to date suggests a
secondary inflammatory response to P acnes
as mentioned above. However, IL-1-alpha expression
has been identified in the microcomedone, and it may
play a role in the development of acne.
Frequency:
- In
the US: Acne vulgaris affects 85-100%
of people at some time during their lives.
Mortality/Morbidity:
- Acne
can cause physical pain and psychosocial
suffering.
- Acne
can lead to scarring.
- A
severe inflammatory variant of acne, acne
fulminans, can be associated with fever,
arthritis, and other systemic symptoms.
Race:
- The
prevalence of acne in North Americans of African
ancestry and whites is similar.
Sex:
- Acne
vulgaris is more common in males than in females
during adolescence.
- It
is more common in women than in men during
adulthood.
Age:
- Acne
vulgaris may be present in the first few weeks
and months of life when a newborn is still under
the influence of maternal hormones and when the
androgen-producing portion of the adrenal gland
is disproportionately large. This neonatal acne
resolves spontaneously.
- Adolescent
acne usually begins prior to the onset of
puberty, when the adrenal gland begins to
produce and release more androgen hormone.
- Acne
is not limited to adolescence. Twelve percent of
women and 5% of men at age 25 years have acne.
By age 45 years, 5% of both men and women still
have acne.
Learn
more information on Acne:
Acne
Vulgaris | Acne
Rosacea | Papules
| Pustules
| Nodules
| Cysts
|